AIDS & Public Policy Journal 2, no. 4 (Fall-Winter 1987): 54-59
Harry Yeide, Jr.
As I begin these reflections on our encounter with AIDS. I find before me a flyer describing yet another medical ethics conference. It advertises two major categories of problems to consider: justice based issues and autonomy based issues. This will hardly seem remarkable to many readers. Indeed, it seems to me that mo
AIDS & Public Policy Journal 2, no. 4 (Fall-Winter 1987): 50-53
David K. Nelson
In a prior article, AIDS and Live Insurance: A Look Behind the Testing Issue, I discussed how seemingly invulnerable institutions like the life and health insurance industries could be prone to severe financial damage as a result of the AIDS epidemic. I opined that the extent of the financial threat to insurers could n
AIDS & Public Policy Journal 2, no. 4 (Fall-Winter 1987): 35-49
Gary J. Wood
Under the guise of a war against AIDS, American politics have recently become enamored of an argument over testing citizens for the antibody to the Human Immunodeficiency Virus (HIV). After sorting through the sordid politics of this issue and reviewing the experience of those people considered at risk of exposure to t
AIDS & Public Policy Journal 2, no. 4 (Fall-Winter 1987): 31-34.
Kristine M. Gebbie
Since the introduction of HIV antibody testing in the spring of 1985, there has been continuous debate over the test, first over its reliability, sensitivity, and specificity; and increasingly over its applicability to various population groups or situations. This article reviews portions of that debate from the perspe
AIDS & Public Policy Journal 2, no. 4 (Fall-Winter 1987): 25-30.
Walter F. Bachelor
There is an easy answer to stopping transmission of the AIDS virus. Like all easy answers, this one is simple, neat, and wrong. The proposal is to give the AIDS antibody test to everyone who is even slightly at risk of exposure to the virus, and to then let each individual s good sense guide him or her into altering th
AIDS & Public Policy Journal 2, no. 4 (Fall-Winter 1987): 14-24.
Larry Gostin
This article will examine compulsory testing and screening programs that seek to determine whether a person has been exposed to the AIDS-related virus, and it will assess the competing legal and public policy justifications for screening specific populations.
AIDS & Public Policy Journal 2, no. 4 (Fall-Winter 1987): 8-13
Christopher J. Collins
This critique of Mr. Bauer s position in favor of AIDS testing provides a rational basis for why such a policy is counterproductive and, as a matter of public health, unsound.
AIDS & Public Policy Journal 2, no. 4 (Fall-Winter 1987): 5-7.
John C. Fletcher
Gary Bauer s discussion of public policy choices to confront and contain the spread of AIDS leaves this reader with three major questions: (1) More routine or symptomatic testing is indeed indicated, but where are the specific details, or even a good outline, of a coherent, ethically supportable plan for such testing?
AIDS & Public Policy Journal 2, no. 4 (Fall-Winter 1987): 3-4.
June E. Osborn
The uses of the antibody test are important and have played a beneficial role in the epidemic. Indeed, we need to enhance the availability of testing and counseling for worried individuals, which we can accomplish both by increasing access to confidential and (as needed) anonymous screening opportunities, and by streng
AIDS & Public Policy Journal 2, no. 4 (Fall-Winter 1987): 1-2.
Gary L. Bauer
In the face of mounting infection and casualties, it is time to stop treating the deadly disease AIDS as a politically protected epidemic. We must move forward with the routine health measures that have enabled us to contain epidemics in the past, such as the syphilis epidemic earlier this century. Routine testing in m
AIDS & Public Policy Journal 2, no. 3 (Summer-Fall 1987): 46-62
Edmund G. Howe
When military physicians treat servicepersons infected with human immunodeficiency virus (HIV), two ethical dilemmas are particularly difficult to resolve: What is the physician to do when these patients indicate that they intend to engage in sexual practices that may endanger others? What action should the physician t
AIDS & Public Policy Journal 2, no. 3 (Summer-Fall 1987): 45
Robert F. Hummel
This recent edition [1987] of Law, Medicine & Health Care, guest-edited by Larry Gostin and William J. Curran, offers a broad range of informed and well-written articles for anyone interested in some of the complex policy and legal issues surrounding AIDS. This is the second of a two-part symposium on AIDS, and the
AIDS & Public Policy Journal 2, no. 3 (Summer-Fall 1987): 44.
Arthur S. Leonard
The past quarter saw the public debate on AIDS focusing heavily on testing. Law journals, of course, tend to lag behind the public debate to a certain extent, so the focus of articles published during the past quarter remained mainly on more traditional issues that have been previously explored, such as AIDS and employ
AIDS & Public Policy Journal 2, no. 3 (Summer-Fall 1987): 37-43
Ronald Turner and David B. Ritter
This article presents a summary of cases that discuss or are related to the issue and impact of AIDS in the employment context. Although this area of law is still in its formative stages, general principles applied by the courts and administrative agencies in other contexts shed some light on the legal issues related t
AIDS & Public Policy Journal 2, no. 3 (Summer-Fall 1987): 33-36
Thomas Vernon
Methods of disease control that are productive and widely accepted for other infections are not applied widely to combat HIV. In some areas, traditional methods have been rejected explicitly by rule or statute. It is not the purpose of this article to attempt an analysis of why that is occurring, much less why AIDS is
AIDS & Public Policy Journal 2, no. 3 (Summer-Fall 1987): 29-32
Stephen C. Joseph
No other public health crisis in recent history has challenged us on so many fronts and on such a scale as the AIDS epidemic. The connection between aids, drugs, and poverty in New York City means that the epidemic is hitting out minority communities especially hard. Against this background of resource demands, a numbe
AIDS & Public Policy Journal 2, no. 3 (Summer-Fall 1987): 26-28
David K. Nelson
Anyone reading the published articles on the AIDS and insurance issues, reviewing the laws and regulations on the subject, or attending AIDS conferences, would with some justification conclude that AIDS presents just one issue to insurers: testing applicants for exposure to the virus. While the importance of the testin
AIDS & Public Policy Journal 2, no. 3 (Summer-Fall 1987): 21-25
Gary J. Wood and Alice Philipson
The following discussion of confidentiality and the right to privacy in the context of human immunodeficiency virus antibody testing is based on the experience of attorneys serving with the AIDS Legal Referral Panel of Bay Area Lawyers for Individual Freedom in San Francisco, California. This panel represents persons w
AIDS & Public Policy Journal 2, no. 3 (Summer-Fall 1987): 11-20
S.S. Fluss and D.K. Latto
In this article, we propose to examine, in a descriptive rather than analytical manner, the extent to which coercive approaches are now being manifested in AIDS legislation. For a number of reasons, it was decided that the U.S. situation should be excluded, largely because of the work being done by others, notably the
AIDS & Public Policy Journal 2, no. 3 (Summer-Fall 1987): 1-10
Nan D. Hunter
The ACLU supports widely available, voluntary testing programs, coupled with adequate counseling and the assurance of anonymity or, if that is not possible, strict protections of confidentiality. The ACLU opposes tests for the AIDS virus that are forcibly imposed. Indeed, for each proposal for enforced testing under di
AIDS & Public Policy Journal 2, no. 2 (Spring-Summer 1987): 62-65.
World Health Organization
The World Health Organization has recognized a responsibility to assume a lead role in global efforts to combat the pandemic of infection with the human immunodeficiency virus (HIV). Current prevention and control efforts are focused primarily on health education and communications and on HIV antibody screening of bloo
AIDS & Public Policy Journal 2, no. 2 (Spring-Summer 1987): 54-61.
Arthur S. Leonard
This bibliography lists articles on legal aspects of the AIDS epidemic which have appeared in academic law reviews, bar journals, legal newspapers, and some books published from 1983 through the middle of 1987.
AIDS & Public Policy Journal 2, no. 2 (Spring-Summer 1987): 50-53.
Peter R. Mathers
The responses of drug investigators and manufacturers to the AIDS epidemic cannot be fully understood without an appreciation of the pervasive federal regulation of those activities. The Federal Food, Drug, and Cosmetic Act (FFDCA), as amended, and the regulations promulgated by the Food and Drug Administration under t
AIDS & Public Policy Journal 2, no. 2 (Spring-Summer 1987): 22-32.
Stephen A. Weitzman and Tina Marcy
The challenge presented and discussed here is the need to accommodate two public policies and two roles of the federal government, one akin to Parens Patriae and the other Consumer Protector. Although the government has reacted to this crisis with unusual speed, the prevalence of the AIDS virus in our communities has c
AIDS & Public Policy Journal 2, no. 2 (Spring-Summer 1987): 17-21.
Emily H. Thomas and Daniel M. Fox
AZT--now named zidovudine and trade-named Retrovir--is the first drug proved to prolong the lives of persons with AIDS, the first to be made available with expedited federal approval, and one of the only two drugs to be sufficiently expensive to generate controversy in recent years. The other is cyclosporine, a breakth
AIDS & Public Policy Journal 2, no. 2 (Spring-Summer 1987): 9-16.
Larry Gostin
There are pressures pulling both ways on researchers, manufacturers, and regulators of the development and marketing of an AIDS vaccine. There are formidable technical, legal, and financial challenges ahead. Society has hardly begun to consider the law, policy, and ethics of taking an AIDS vaccine from the test tube, t
AIDS & Public Policy Journal 2, no. 2 (Spring-Summer 1987): 6-8.
Robert J. Levine
In this article, I shall concentrate on two highly controversial aspects of development of new drugs for the treatment of AIDS. These are: Is the placebo-controlled randomized clinical trial appropriate for the evaluation of these new drugs? And, during the period of evaluation of new drugs, should they be made availab
AIDS & Public Policy Journal 2, no. 2 (Spring-Summer 1987): 1-5.
Mathilde Krim
There is a pressing, desperate need and a demand for new therapies: new therapies for the opportunistic infections and malignancies that are the immediate cause of death in AIDS, and therapies for the underlying infection with the retrovirus recently renamed human immunodeficiency virus (HIV), that which destroys the a
AIDS & Public Policy Journal 2, no. 1 (Winter 1987): 32-33
American Council of Life Insurance
AIDS (acquired immunodeficiency syndrome) poses major problems for insurers and policyholders, as well as for the whole of society. If recent trends in the spread of this national health threat continue, the insurance industry could be faced with billions of dollars in AIDS-related medical, disability and death claims
AIDS & Public Policy Journal 2, no. 1 (Winter 1987): 28-31
James F. Childress
When commentators argue that the AIDS virus has no civil rights, their language often suggests that the moral imperative to control AIDS cancels all other moral imperatives and suspends our moral universe. Of course, they rarely follow their rhetoric to the conclusion of compulsory universal screening followed by mass
AIDS & Public Policy Journal 2, no. 1 (Winter 1987): 25-27
Daniel M. Fox
Cost is a metaphor for some of the terrible effects of the AIDS epidemic. The media have displayed the costs of treating AIDS as a way of calling attention to the effects of the disease on patients, their families and friends, on hospitals, and on public budgets. Hospital managers worry about the costs of treating AIDS
AIDS & Public Policy Journal 2, no. 1 (Winter 1987): 19-24.
Mark Scherzer
Though the insurance premiums of gay people may have subsidized benefits to others in the past, gay people clearly are seen not to have a claim for reciprocal support when the costs of their health care or death exceed those of others. Society s reaction to this epidemic has been shaped in large part by its views about
AIDS & Public Policy Journal 2, no. 1 (Winter 1987): 15-18.
Russell P. Iuculano
The development of criteria for fair underwriting of life and health insurance for persons medically at high risk for AIDS has presented daunting challenges to both the insurance industry and state legislators and regulators. In the District of Columbia, the industry was faced with the most sweeping legislation of its
AIDS & Public Policy Journal 2, no. 1 (Winter 1987): 11-14.
Gerald M. Oppenheimer and Robert A. Padgug
In examining AIDS and health insurance, we must deal with two sets of particularities, that of AIDS as a pattern of disease and that of private health insurance as a system of access to and payment for health care.
AIDS & Public Policy Journal 2, no. 1 (Winter 1987): 2-10.
Jack H. Blaine
While much debate has centered on the issue of voluntary vs. mandatory testing of various segments of the public, attention should rightfully be focused on carriers of the virus as they may be spreading the disease to others. Recent studies indicate that as many as 34 percent of infected persons have gone on to develop
AIDS & Public Policy Journal 2, no. 1 (Winter 1987): 1
Robert F. Hummel
This issue of the AIDS & Public Policy Journal presents some rather diverse views with regard to HIV testing, its use by insurance companies, and the potential consequences of various public policies. The insurance and HIV testing debate is illustrative of the need for a credible national policy forum to consider t
This information is designed to support, not replace, the relationship that exists between you and your doctor.